Neuroendocrine differentiation in prostatic carcinomas: histogenesis, biology, clinical relevance, and future therapeutical perspectives.
about
ERG-TMPRSS2 rearrangement is shared by concurrent prostatic adenocarcinoma and prostatic small cell carcinoma and absent in small cell carcinoma of the urinary bladder: evidence supporting monoclonal originShared TP53 gene mutation in morphologically and phenotypically distinct concurrent primary small cell neuroendocrine carcinoma and adenocarcinoma of the prostate.Carboplatin-etoposide combination chemotherapy in metastatic castration-resistant prostate cancer: A retrospective studyProstate carcinoma with neuroendocrine differentiation: case report and literature review.A neuroendocrine/small cell prostate carcinoma xenograft-LuCaP 49N-Myc Drives Neuroendocrine Prostate Cancer Initiated from Human Prostate Epithelial Cells.Impact of age on clinical presentation, treatment, and cancer-specific survival of patients with small-cell carcinoma of the prostate.Small-cell neuroendocrine carcinoma of the prostate: are heterotransplants a better experimental model?Small cell carcinoma of the prostate.FOXA2 is a sensitive and specific marker for small cell neuroendocrine carcinoma of the prostate.Small cell carcinoma of the prostate expressing prostate-specific antigen and showing syndrome of inappropriate secretion of antidiuretic hormone: an autopsy case report.Small cell carcinoma of the prostate presenting with skin metastasis: a case report.Complete chemotherapeutic regression of a non-metastatic case of primary pure small cell carcinoma of the prostateProstate cancer with small-cell morphology: an immunophenotypic subdivision.Gene expression signatures of neuroendocrine prostate cancer and primary small cell prostatic carcinoma.Targeting the MYCN-PARP-DNA Damage Response Pathway in Neuroendocrine Prostate Cancer.Ectopic Cushing syndrome due to neuroendocrine prostatic cancer.The long noncoding RNA landscape of neuroendocrine prostate cancer and its clinical implications.Roles of Alternative RNA Splicing of the Bif-1 Gene by SRRM4 During the Development of Treatment-induced Neuroendocrine Prostate Cancer.
P2860
Q31005436-1F0CE9DF-5AEB-4750-B197-217F4234AA2AQ33397762-AB095C7E-A9CB-45D0-AE2D-198AA856750BQ33429467-7B27F771-017F-400B-9888-934F5132D6F4Q34487391-CD9FF48F-4EC0-466A-819D-9F2AC55CB6C3Q35747677-8D387069-E9DF-4DC2-B8B5-088B5DFF25EDQ35980945-2F793D5E-8391-479F-BD18-A2FA5DE67519Q37027412-A8DFCC0B-1BF8-47E9-AE0C-33ADAC96A8BEQ37659820-7CA9ED1B-F7A5-49BD-B624-4BC41C64FA66Q38188869-B93C5D3A-A2EE-48B6-A330-DEAF70240796Q38722718-0FF3CA3F-58A2-4826-9903-55B53C2384CEQ39669715-97FA0E09-7FA8-429D-AC02-42CA234F71D8Q40342788-6EEB54B3-755B-4A02-BABC-A751D040D86BQ41832294-97822973-B729-43E8-B9F4-D20CCBC6D244Q46816625-7105A516-578D-4E2E-BEBC-460B09020061Q47140347-01EBB326-AB57-47A0-8320-69DF5242C541Q47595568-058AA011-A3A2-41C7-8517-ABF680925FB6Q52983014-BAEE542B-CA84-48BC-B05D-0F13F2C25194Q53682879-2A8BEE27-0A99-42D2-9E6D-79CD326A08F8Q55291143-61602172-7A05-4316-B887-A104F89265AF
P2860
Neuroendocrine differentiation in prostatic carcinomas: histogenesis, biology, clinical relevance, and future therapeutical perspectives.
description
1999 nî lūn-bûn
@nan
1999 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Neuroendocrine differentiation ...... re therapeutical perspectives.
@ast
Neuroendocrine differentiation ...... re therapeutical perspectives.
@en
type
label
Neuroendocrine differentiation ...... re therapeutical perspectives.
@ast
Neuroendocrine differentiation ...... re therapeutical perspectives.
@en
prefLabel
Neuroendocrine differentiation ...... re therapeutical perspectives.
@ast
Neuroendocrine differentiation ...... re therapeutical perspectives.
@en
P2093
P356
P1476
Neuroendocrine differentiation ...... re therapeutical perspectives.
@en
P2093
P304
P356
10.1159/000030376
P577
1999-01-01T00:00:00Z